Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Virpax Pharmaceuticals
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
August 08, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Regains Compliance with Nasdaq Minimum Bid Price
July 24, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
July 10, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
May 29, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
April 30, 2024
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
November 17, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
October 31, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Gerald W. Bruce Appointed President and CEO of Novvae™ Pharmaceuticals
October 02, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
September 18, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Updates on Litigation
September 05, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery
July 13, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces CFO Transition
June 20, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Reports on Progress of Envelta™
April 05, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors
March 28, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology (MET)
February 13, 2023
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pursues OTC Medical Device Pathway for AnQlar™
July 05, 2022
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Will Pursue Direct to OTC Pathway for Epoladerm™ for Pain Associated with Osteoarthritis
June 27, 2022
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021
September 02, 2021
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
July 30, 2021
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications
June 21, 2021
From
Virpax Pharmaceuticals
Via
Business Wire
Tickers
VRPX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit